Reproducibility of Impedance Cardiography Hemodynamic Measures in Clinically Stable Heart Failure Patients

作者: Barry H. Greenberg , Denise D. Hermann , Maryann F. Pranulis , Lucia Lazio , David Cloutier

DOI: 10.1111/J.1527-5299.2000.80140.X

关键词:

摘要: BACKGROUND AND AIMS. One of the greatest challenges confronting physicians who are managing care patients with heart failure is to acquire objective data that signals treatment effectiveness and/or disease progression. The aim this study was twofold: 1) determine extent which (real time) impedance cardiography measurements obtained a specific medical device (the BioZ) were reproducible in outpatients clinically stable failure; and 2) establish "normal" ranges one week hemodynamic variability population patients. Information nature would help clinical cardiologists primary practitioners evaluate implications their patient's visit-to-visit variability. METHODS. A group, prospective, time series design used. sample consisted 62 had being treated an outpatient clinic at university center. BioZ measures cardiac output, contractility, after load five points time: two, 10, 60 minutes resting following 40-50 foot walk on first day two 10 second day, later. RESULTS. Small but significant changes output index (mainly due rate) seen during 60-minute period one. Stroke did not change period. In general, reproducibility between taken same days quite good. Establishment 95% confidence intervals helped define boundaries population. Further evaluation four whose values exceeded revealed unexpected, potentially relevant could have accounted for interday Conclusion. responsive activity-rest interval clinic. better measure patient status than or index. (c)2000 by CHF, Inc.

参考文章(11)
Markus J. Osypka, Donald P. Bernstein, Electrophysiologic Principles and Theory of Stroke Volume Determination by Thoracic Electrical Bioimpedance AACN Advanced Critical Care. ,vol. 10, pp. 385- 399 ,(1999) , 10.1097/00044067-199908000-00008
J. Martin Bland, DouglasG. Altman, Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet. ,vol. 327, pp. 307- 310 ,(1986) , 10.1016/S0140-6736(86)90837-8
Segalit Tsadok, The historical evolution of bioimpedance. AACN Advanced Critical Care. ,vol. 10, pp. 371- 384 ,(1999) , 10.1097/00044067-199908000-00007
Jay N Cohn, Overview of the treatment of heart failure. American Journal of Cardiology. ,vol. 80, pp. 2- ,(1997) , 10.1016/S0002-9149(97)00843-6
S. H. L. Thomas, Impedance cardiography using the Sramek-Bernstein method: accuracy and variability at rest and during exercise. British Journal of Clinical Pharmacology. ,vol. 34, pp. 467- 476 ,(1992)
Gerfried Gratze, Jürgen Fortin, Albert Holler, Karin Grasenick, Gert Pfurtscheller, Paul Wach, Josef Schönegger, Peter Kotanko, Falko Skrabal, A software package for non-invasive, real-time beat-to-beat monitoring of stroke volume, blood pressure, total peripheral resistance and for assessment of autonomic function Computers in Biology and Medicine. ,vol. 28, pp. 121- 142 ,(1998) , 10.1016/S0010-4825(98)00005-5
B B Sramek, Physiologic chart for rapid identification of causes of abnormal haemodynamics. Annals Academy of Medicine Singapore. ,vol. 23, pp. 26- 32 ,(1994)
Rowland M, Beckett Ah, Turner P, AKUFO AND IBARAPA. The Lancet. ,vol. 1, pp. 307- ,(1965)